| Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? | |
MedLine Citation:
|
PMID: 20132025 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To determine whether a biological marker of ischemia, ischemia-modified albumin (IMA), alone or normalized to albumin serum concentration, was modified during the course of pregnancy and so could be used for discrimination between normal pregnancy and preeclampsia. METHODS: Serum IMA concentrations and IMA to serum albumin ratio (IMA/alb) were compared in 22 nonpregnant healthy women (NP), 19 healthy pregnant women (HP) and 20 pre-eclamptic women (PE). Influence of age of gestation on these markers was also investigated. RESULTS: IMA to albumin ratio (IMA/alb) was significantly increased in HP compared with NP (IMA/alb. HP: 2.60 +/- 0.38 kU/g and IMA/alb. NP: 2.10 +/- 0.22 kU/g; p < 0.05). Both IMA and IMA/alb were significantly elevated during PE compared with HP (IMA HP: 98.4 +/- 9.2 kU/l and IMA PE 116.9 +/- 12.3 kU/l, p < 0.001; IMA/alb HP: 2.60 +/- 0.38 kU/g and IMA/alb PE: 3.79 +/- 0.75 kU/g p < 0.001)). Both IMA and IMA/alb were increased in PE up to delivery. No correlation could be demonstrated between gestational age and maternal IMA both in HP (r = 0.13; p = 0.071) or PE (r = 0.05; p = 0.318). CONCLUSIONS: IMA and IMA normalized to albumin appear to be significantly increased during pathological pregnancies. These results confirm that IMA could be used as a biological marker of preeclampsia. These data need to be confirmed by determining intra-individual IMA change during normal and pathological pregnancy. |
Authors:
|
Benjamin Gafsou; Guillaume Lefèvre; Bernadette Hennache; Véronique Houfflin Debarge; Anne-Sophie Ducloy-Bouthors |
Related Documents
:
|
19952865 - Autoantibodies to folate receptor alpha during early pregnancy and risk of oral clefts ... 2060505 - Serum folic acid levels in epileptic mothers and their relationship to congenital malfo... 19003635 - Serum inhibin a level in preeclampsia and normotensive pregnancy. 781575 - Identification of an immunosuppressive factor in pregnancy serum. 9526705 - Leukemia inhibitory factor (lif) production by human decidua and its relationship with ... 17872995 - Rapid assimilation of yolk enhances growth and development of lizard embryos from a col... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Hypertension in pregnancy Volume: 29 ISSN: 1525-6065 ISO Abbreviation: Hypertens Pregnancy Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-02-05 Completed Date: 2010-05-03 Revised Date: 2014-07-23 |
Medline Journal Info:
|
Nlm Unique ID: 9421297 Medline TA: Hypertens Pregnancy Country: England |
Other Details:
|
Languages: eng Pagination: 101-11 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biological Markers
/
metabolism Chi-Square Distribution Female Humans Ischemia / metabolism* Pre-Eclampsia / metabolism* Pregnancy Serum Albumin / metabolism* Statistics, Nonparametric |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Serum Albumin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lipid levels including oxidized LDL in women with history of preeclampsia.
Next Document: Second trimester maternal serum cystatin C levels in preeclamptic and normotensive pregnancies: A sm...